Once that aid was received, countries felt obliged to rule out the possibility of partial default, the stage that Greece has reached now.

Although one promising vaccine has finally reached end-stage clinical trials, it provides only partial protection against the disease, which kills up to one million people a year.

While the domestic researches are comparatively deficient and fragmentary, some only touches the partial contents and others pause in the introduction stage, not systematic.